A Lang

403 citations
13 papers · 313 indexed · h-index 8
Topics
Osteoarthritis Treatment and Mechanisms (4 papers)Protease and Inhibitor Mechanisms (2 papers)Bone fractures and treatments (2 papers)

In The Last Decade

A Lang

13 papers receiving 307 citations

Peers

A Lang
Comparison fields: 5 of 68
  • Rheumatology 130
  • Cancer Research 107
  • Molecular Biology 83
  • Surgery 69
  • Oncology 46
Replace Peter LEM van Lent with:
Peter LEM van Lent Netherlands
Kirsty L. Culley United States
J. Flannelly United Kingdom
A. Cooper United Kingdom
Kendal McCulloch United Kingdom
S.E. Usmani Canada
Irina Kerna Estonia
Stefan N. Andersen Netherlands
Susanne Adam Germany
Duenpim Parisuthiman United States
A Lang relative to Peter LEM van Lent Netherlands Peter LEM van Lent's profile →
Citations per field
00.5×1.5×1.9×
Peter LEM van Lent · 1×
Citations per year

Countries citing papers authored by A Lang

Since Specialization
Citations

This map shows the geographic impact of A Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Lang more than expected).

Fields of papers citing papers by A Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Lang. The network helps show where A Lang may publish in the future.

Co-authorship network of co-authors of A Lang

This figure shows the co-authorship network connecting the top 25 collaborators of A Lang. A scholar is included among the top collaborators of A Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Lang. A Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 1
2 2
3 9
4 1
5 1
6 34
7
The relative importance of cysteine peptidases in osteoarthritis.
56
8 25
9 70
10 64
11 37
12
Tubular adenoma of breast.
10
13
[Anatomy of ligamentum teres femoris].
3

About A Lang

A Lang is a scholar working on Developmental Biology, Cancer Research and Rheumatology, having authored 13 papers that have together received 313 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (4 papers), Protease and Inhibitor Mechanisms (2 papers) and Bone fractures and treatments (2 papers). The work is most often cited by research in Rheumatology (130 citations), Immunology and Allergy (44 citations) and Cancer Research (107 citations). A Lang has collaborated with scholars based in Switzerland, United States and Australia. Frequent co-authors include Antonio Baici, R Kissling, C. Merlin, Gregor Zünd, Claudio Dora, Peter Groscurth, Marko Turina, Mário Lachat, Oliver Reuthebuch and Leo J. Mahoney. Their work appears in journals such as Annals of the Rheumatic Diseases, Injury and European Journal of Cardio-Thoracic Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026